elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37554153-1836311B-9520-4503-BF1C-3D07A163A850
Q37554153-1836311B-9520-4503-BF1C-3D07A163A850
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37554153-1836311B-9520-4503-BF1C-3D07A163A850
Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 1: Prevention.
P2860
Q37554153-1836311B-9520-4503-BF1C-3D07A163A850
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37554153-1836311B-9520-4503-BF1C-3D07A163A850
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
15af204aed9e48a45e969ab6408138081ae6dd13
P2860
Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin K in the treatment of warfarin-associated coagulopathy. A randomized, controlled trial.